Head-to-head · WeighScore
Luvo Health vs Zealthy
The verdict
Luvo Health takes it — 61/100 to 46.7/100.
Luvo Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Multi-program telehealth brand from LUVO HEALTH, INC.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Luvo Health | Zealthy |
|---|---|---|
| WeighScore | 61/100 | 46.7/100 |
| Grade | C | C |
| Scorecard rank | #305 | #496 |
| Semaglutide | $249/mo (compounded) | $286/mo (starting dose, plus a separate fee, compounded) |
| Tirzepatide | $339/mo (compounded) | $351/mo (starting dose, plus a separate fee, compounded) |
| Coverage | Coverage not published | 34 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #305 · C
Strengths
- Full price list published openly, by medication and by commitment length, with no intake required
- Offers both compounded and brand-name Ozempic and Zepbound in one place
- Oral semaglutide tablets available as well as injections
- Full refund if a provider disqualifies you before medication is ordered
- LegitScript certification verified against the issued seal, not just the badge
Where it loses points
- Billed per 4 weeks, not per month, which is 13 charges a year rather than 12
- You are charged for the first period as soon as you complete the intake form, before a clinician has reviewed you
- Refunds stop once medication is ordered, and for new patients with no video visit that is at intake submission
- Cancellation needs 72 hours notice before the billing date or you are charged for another cycle
- Bundle refunds are recalculated at the standard non-bundled rate, so the multi-month discount is clawed back
Graded #496 · C
Strengths
- Serves 34 states — meaningful nationwide footprint
- Asynchronous model removes friction for patients who don't want a video visit
- Independent licensed prescribers retain full clinical authority
Where it loses points
- Active Novo Nordisk false-advertising lawsuit alleging trademark infringement and marketing compounded drugs as FDA-approved alternatives
- Active DOJ/FTC enforcement alleging undisclosed subscription terms, locked cancellation, and unauthorized health-data sharing
- Founder previously ran Cerebral, which settled with the FTC in 2024 over similar deceptive practices
- Recently rebranded to Gronk Inc. amid active enforcement
- FDA issued this company a warning letter dated 1 September 2025; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.